Key result
Loss of UCP2 in mtDNA mutator mice shortened mean lifespan by 14% and accelerated mitochondrial cardiomyopathy without altering ROS production or uncoupling activity.
UCP2 upregulation in mitochondrial cardiomyopathy acts as a beneficial adaptive response that improves fatty acid oxidation and prolongs lifespan, challenging the traditional 'uncoupling to survive' hypothesis.
Answers are grounded in this paper and cite their sources.
UCP2 upregulation may adaptively prolong lifespan in mitochondrial cardiomyopathy; challenges uncoupling-to-survive hypothesis but leaves open human relevance.
Although mitochondrial dysfunction is often accompanied by excessive reactive oxygen species (ROS) production, we previously showed that an increase in random somatic mtDNA mutations does not result in increased oxidative stress. Normal levels of ROS and oxidative stress could also be a result of an active compensatory mechanism such as a mild increase in proton leak. Uncoupling protein 2 (UCP2) was proposed to play such a role in many physiological situations. However, we show that upregulation of UCP2 in mtDNA mutator mice is not associated with altered proton leak kinetics or ROS production, challenging the current view on the role of UCP2 in energy metabolism. Instead, our results argue that high UCP2 levels allow better utilization of fatty acid oxidation resulting in a beneficial effect on mitochondrial function in heart, postponing systemic lactic acidosis and resulting in longer lifespan in these mice. This study proposes a novel mechanism for an adaptive response to mitochondrial cardiomyopathy that links changes in metabolism to amelioration of respiratory chain deficiency and longer lifespan.
No takes yet. Share an insight, caveat, or question.
Kukat et al. (2014) studied Mitochondrial dysfunction and premature aging. UCP2 deficiency vs. UCP2 wild-type (mtDNA mutator mice) was evaluated on Mean lifespan (14% shorter). Loss of UCP2 in mtDNA mutator mice shortened mean lifespan by 14% and accelerated mitochondrial cardiomyopathy without altering ROS production or uncoupling activity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: